HLB제넥스

187420KOSDAQ기초 의약물질 제조업

58.5 / 100

Reference Date: 2026-07-24

Financial Score21.5 / 40

News Sentiment20.0 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 20.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HLB제넥스 is a biotech company founded in 2000, specializing in the development and production of customized enzymes and bio-healthcare materials using core technologies like microbial display and recombinant protein secretion. Its main business areas include industrial specialty enzymes, bio-healthcare materials, and microbiome-enzyme products, with key offerings such as eco-friendly catalase, lactase for GOS production, and nattokinase for cardiovascular health. The company is also advancing its pipeline drug GF103, an oral treatment for wet age-related macular degeneration, currently preparing for Phase I clinical trials.

Number of Employees

82people

Average Salary

57.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

2.14Industry Average 25.448.0Point

Half of industry avg (excellent)

PBR

0.99Industry Average 1.264.0Point

In line with industry avg

ROE

55.20Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

33.29Industry Average 6.620.0Point

5.0x industry avg (risky)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲26.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲122.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -4.4% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 80

Positive
진양곤 HLB의장, 계열사 주식매수…"올해만 50번"
HLB그룹 경영진의 지속적인 주식 매수는 책임 경영 의지를 보여주며 주가 하락 속에서도 긍정적 신호를 전달합니다.
Positive
HLB그룹, 진양곤 의장·계열사 대표이사 자사 주식 매수
HLB그룹 의장의 대규모 주식 매수로 인해 HLB제넥스의 신뢰도와 시장 가치 상승 기대가 높아졌다.
Positive
HLB제넥스 김도연 대표, 자사주 3만여주 추가 매입 [공시록]
HLB제넥스의 김도연 대표이사가 추가 자사주 매입으로 책임경영 의지를 보여주며, 주가 하락에도 불구하고 회사 성장에 대한 긍정적 전망을 반영.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 1,657Won52-week high 3,36552-week low 1,462

1-month return0.0Point

1m -20.34% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-07-22
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-20
Neutral주식등의대량보유상황보고서(일반)2026-07-20
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-16
Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-06